Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

LRRK2 is not a significant cause of Parkinson's disease in French-Canadians.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques - 1 Aug 2007

Dupré Nicolas, Rivière Jean-Baptiste, Myers Richard H, Provencher Pierre, Pourcher Emmanuelle, Emond François, Rouleau Guy A

Abstract excerpt

BACKGROUND: An old founder mutation (G2019S) was found with high frequency in the North African Arabs (30%) and Ashkenazi Jews (18% ). OBJECTIVE: Demonstrate if mutations in the LRRK2 gene are a significant cause of Parkinson's disease (PD) in the French-Canadian founder population. METHODS: Cases were recruited through a designated movement disorder clinic in Quebec City. Every index case had to meet the Ward...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age of Onset
Share to Founder Effect

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2

Share to Parkinson Disease

Share to Protein Serine-Threonine Kinases

Share to Quebec

Share to White People

Source

Identifiers

PMID: 17803032
DOI: 10.1017/s0317167100006776

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

LRRK2 is not a significant cause of Parkinson's disease in French-Canadians.PMID 17803032Read ↗

LRRK2 gene in Parkinson disease: mutation analysis and case control association study.Semantic proximity Read ↗

Leucine-rich repeat kinase 2 (LRRK2) mutations in a Swedish Parkinson cohort and a healthy nonagenarian.Semantic proximity Read ↗

Common variants of LRRK2 are not associated with sporadic Parkinson's disease.Semantic proximity Read ↗

G2019S LRRK2 mutation in French and North African families with Parkinson's disease.Semantic proximity Read ↗

Prevalence of the LRRK2 G2019S mutation in a UK community based idiopathic Parkinson's disease cohort.Semantic proximity Read ↗

Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patients.Semantic proximity Read ↗

Identification of four novel potentially Parkinson's disease associated LRRK2 variations among Iranian patients.Semantic proximity Read ↗

Mutations in LRRK2 other than G2019S are rare in a north American-based sample of familial Parkinson's disease.Semantic proximity Read ↗

RIC3 variants are not associated with Parkinson's disease in French-Canadians and French.Semantic proximity Read ↗

LRRK2 screening in a Canadian Parkinson's disease cohort.Semantic proximity Read ↗

Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.Semantic proximity Read ↗

Pathogenic Lrrk2 substitutions and Amyotrophic lateral sclerosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.